The Impact of Simvastatin on Lipidomic Markers of Cardiovascular Risk in Human Liver Cells Is Secondary to the Modulation of Intracellular Cholesterol
Metabolites
Yvette L Schooneveldt 1 2 3, Corey Giles 1 4, Michael F Keating 3, Natalie A Mellett 1, Aaron W Jurrjens 1 2 3, Sudip Paul 1 4, Anna C Calkin 2 3 4, Peter J Meikle 1 2 4
DOI: 10.3390/metabo11060340
Powered by Feebly
